Compounds · Skin & hair · Anti-inflammatory peptide for skin conditions
KPV
α-MSH(11-13), Alpha-MSH(11-13), Ac-Lys-Pro-Val
C-terminal tripeptide fragment of alpha-MSH, studied for anti-inflammatory and antimicrobial effects. Investigated for colitis, psoriasis, and wound healing without the immunosuppressive downsides of steroids.
0.2–0.5 mg daily
Research score 60/100. Reference only, not a prescription.
- Anti-inflammatory
- Skin Health
- Wound Healing
- Inflammation Resolution
- US status
- Research Chemical
- Approval
- Research Chemical Only
- Evidence
- Preclinical studies and limited human experimental use (topical/oral).
- Research score
- 60 / 100
- Indication
- Research Only - No Medical Indication
- Origin
- USA
- Source category
- Skin & Dermatology
- Status group
- Research chemical
Mechanism
Acts independently of melanocortin receptors to block pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) and NF-κB signaling in keratinocytes and immune cells, without triggering the pigmentation effects of its parent hormone α-MSH.
Safety file
Good safety profile in available studies; mild skin irritation topically and mild GI upset orally, but no long-term human data.
- Well-tolerated with minimal side effects
Reconstitution
| Vial | 2 mL water | 3 mL water |
|---|---|---|
| 10 mg | 5 mg/mL | 3.33 mg/mL |
- Use bacteriostatic water as the diluent.
- Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
- Swirl gently to mix, then leave it to dissolve. Do not shake.
- Give it a few minutes. The finished solution should be clear and colourless.
Protocol
Route: Subcutaneous
Standard protocol (subcutaneous)
- 0.25 mg (250 mcg) once daily to start, up to 0.5 mg
- At a 2 mL fill (5 mg/mL), 0.25 mg is 5 units and 0.5 mg is 10 units
- For gut-focused use it is often run daily through an active flare
Dosing detail
- Common daily dose is around 0.2 mg to 0.5 mg, starting at 0.25 mg.
- Once daily subcutaneous is the usual approach.
- Often used in shorter courses during an active inflammatory or gut issue rather than continuously.
- Community dosing data for KPV is thinner than for BPC-157 or TB-500, so start conservative and assess.
Duration
- Typically a 2 to 4 week course around an inflammatory issue, then stop or taper. Repeat as needed around flares.
Notes
- An anti-inflammatory tripeptide, popular for gut inflammation and skin issues.
- Generally well tolerated.
- Rotate sites.
Storage and handling
- Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
- Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
- Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
- If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.
NovaEvum vial
Worksheet
2 mL bacteriostatic water into 10 mg gives 5 mg/mL, 50 mcg/unit. A 250 mcg amount is 5 units.
- Catalog fill
- 10 mg
- Typical water
- 2 mL
- Route
- Subcutaneous
- Cycle
- 2–4 weeks.
| Step | Amount | Frequency | Notes |
|---|---|---|---|
| Common range | 200–250 mcg | Once daily | — |
| Upper cited range | 500 mcg | Once daily | — |
- Also a component of KLOW. Do not stack a full KPV vial on top of KLOW without accounting for the overlap.
- Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
- Amounts on this sheet are reconstitution math for the vial, not a recommendation.